This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
March 9-11, 2026
San Diego Convention CenterSan Diego, CA, USA

Justin Scoble
Vice President of Technical Operations at Caribou Biosciences, Inc.
Speaker

Profile

Justin is the Vice President of Technical Operations at Caribou Biosciences which is a leading clinical-stage CRISPR genome-editing biopharmaceutical company advancing a pipeline of off-the-shelf CAR-T therapies for the treatment of patients with hematologic malignancies. He is responsible for developing, manufacturing, testing, and distributing the company’s critical raw materials and investigational products. Justin has over 20 years of development experience in the biotechnology sector with a focus on immuno-oncology including roles at Actym Therapeutics, Cerus Corporation, Anza Therapeutics, and Aduro Biotech. Justin earned his undergraduate degree in Biology from Vassar College, his Ph.D. in Molecular and Cell Biology from the University of California, Berkeley, and did his post-doctoral fellowship at the University of California, San Francisco.



Agenda Sessions

  • Scaling genome-edited allogeneic CAR-T manufacturing to increase access to cell therapies

    9:00am